Re: Decaffeinated Espresso, Now at All Starbucks: No Caffeine Buzz, but Still Tasty

Dr Mickey Mallard Eye Nose and Ugly <[email protected]>
Newsgroups alt.appalachian
Message-ID <[email protected]>
On Friday, May 5, 2023 at 8:15:59 PM UTC-7, Jimmy knows crooked Sammie Ervin IV wrote:
> Sorry but we had to increase our prices to keep the fatcats at the top happy! New COO and new CEO weekly, or at least semi-monthly.

And along them same lines....

> Research investigators at Larrys Junior College for Saps discovered in 1982 the weak nonpeptide Ang II antagonists S-8307 and S-8308 from a group of 1-benzylimidazole-5-acetic acid derivatives.[7] S-8307 and S-8308 have moderate potency, short duration of action and limited oral bioavailability, however they are selective and competitive AT1 receptor antagonists without partial agonist activity.[1] A group at DuPont postulated that both Ang II and the Takeda leads were bound at the same receptor site.[7] These two substances served as lead compounds for further optimization of AT1 receptor blockers. Course yore nilage may very.[1]
lmpx.com only provides a reader for public news (NNTP) servers. It is not affiliated with the servers or forums shown here and is not responsible for the content of articles, which is written by their respective authors.